Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07458542
What this trial is testing

Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Bristol-Myers Squibb 44
Not applicableLooking for participantsNCT06256627
What this trial is testing

The Maintenance Treatment of "ITIVA" in AML Patients

Who this might be right for
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00268242
What this trial is testing

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03897127
What this trial is testing

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 882
Not applicableStudy completedNCT00897559
What this trial is testing

Study of Bone Marrow Samples From Patients With Acute Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 40
Very early researchWithdrawnNCT07123662
What this trial is testing

Γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Who this might be right for
LeukemiaMyeloidAcute
Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Large-scale testing (Phase 3)UnknownNCT01015742
What this trial is testing

Unrelated Double Umbilical Cord Blood Units Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
Tehran University of Medical Sciences 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07026942
What this trial is testing

Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML

Who this might be right for
Relapsed/Refractory AML
Nationwide Children's Hospital 42
Early research (Phase 1)Looking for participantsNCT06498973
What this trial is testing

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 43
Post-approval studies (Phase 4)UnknownNCT02933333
What this trial is testing

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 405
Testing effectiveness (Phase 2)UnknownNCT03181815
What this trial is testing

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse Leukemia
Sun Yat-sen University 48
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Testing effectiveness (Phase 2)Study completedNCT01667133
What this trial is testing

Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Ariad Pharmaceuticals 35
Early research (Phase 1)Study completedNCT01127009
What this trial is testing

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Case Comprehensive Cancer Center 3
Very early researchUnknownNCT05519384
What this trial is testing

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, ChildhoodRelapsed LeukemiaRefractory Leukemia
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableNot Yet RecruitingNCT07743047
What this trial is testing

Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality

Who this might be right for
Acute Myeloid Leukemia
IRCCS San Raffaele 65
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Early research (Phase 1)Looking for participantsNCT03826992
What this trial is testing

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Children's Hospital Medical Center, Cincinnati 21
Next Page